Know Labs: Little-Known But Highly Capable Company In The MedTech Industry

Jan. 31, 2022 9:00 AM ETKnow Labs, Inc. (KNW)10 Comments
Ari Zoldan profile picture
Ari Zoldan


  • Know Labs has developed a technology platform that can provide blood glucose readings non-invasively.
  • Internal scientific studies compared Know Lab’s sensors with products like Dexcom’s G6, Abbott’s Freestyle Libre, and Roche’s Accu-Chek Fingerstick.
  • The global blood glucose monitoring market is a multi-billion-dollar market, growing at a CAGR of 9.6%, and is expected to reach a value of $27.2 billion by 2026.
  • Adoption of continuous glucose monitoring (CGM) devices is expected to increase among both Type 1 and Type 2 diabetic patients.
  • With the reduced cost and ease of use, CGM devices can reach the larger addressable market of pre-diabetics and nondiabetics.
Close up of a modern innovative smartwatch

yacobchuk/iStock via Getty Images

At the time of writing and based on internal scientific studies, Know Labs’ (KNWN) technology seems superior to DexCom’s (DXCM) and Abbott's (ABT) CGM devices. However, the upcoming FDA trials will be the final test of both the accuracy

This article was written by

Ari Zoldan profile picture
Ari Zoldan is the CEO of Quantum Media Group, a marketing and media agency based in New York City. As an on-air TV personality, Ari can be seen regularly on FOX, CNN & CNBC covering technology, media and business trends. Ari serves as Chair of the Media & Development committee for The Zahn Center for Innovation at City College. In his journalistic capacity Ari and has been to dozens of war torn and conflicted zones such as South Sudan, Uganda, Nicaragua, Haiti, Burma, & Guinea. He holds press credentials on Capitol Hill and the United Nations and is a member of the National Press Club in Washington, DC.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (10)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.